Jushi Holdings Inc. (OTCMKTS:JUSHF - Free Report) - Atb Cap Markets issued their Q1 2025 EPS estimates for Jushi in a note issued to investors on Sunday, March 9th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings of ($0.07) per share for the quarter. Atb Cap Markets has a "Strong Sell" rating on the stock. The consensus estimate for Jushi's current full-year earnings is ($0.23) per share. Atb Cap Markets also issued estimates for Jushi's Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.06) EPS, FY2025 earnings at ($0.25) EPS, FY2026 earnings at ($0.20) EPS, FY2027 earnings at ($0.16) EPS and FY2028 earnings at ($0.12) EPS.
Jushi (OTCMKTS:JUSHF - Get Free Report) last released its quarterly earnings results on Wednesday, March 12th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.02). The business had revenue of $65.86 million for the quarter, compared to analyst estimates of $64.03 million.
Jushi Price Performance
Shares of JUSHF opened at $0.27 on Wednesday. The firm has a market capitalization of $53.09 million, a PE ratio of -1.00 and a beta of -0.83. Jushi has a 1-year low of $0.22 and a 1-year high of $0.92. The company's fifty day moving average price is $0.33 and its 200-day moving average price is $0.39.
Jushi Company Profile
(
Get Free Report)
Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jushi, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jushi wasn't on the list.
While Jushi currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
